# Evaluation of the Analytical Performance of ALLEGRO™ Instrument

> **NCT04096313** · — · COMPLETED · sponsor: **Nova Biomedical** · enrollment: 628 (actual)

## Conditions studied

- Diabetes Mellitus
- Kidney Diseases
- Metabolic Disease

## Interventions

- **DIAGNOSTIC_TEST:** HbA1c, Lipids, UACR

## Key facts

- **NCT ID:** NCT04096313
- **Lead sponsor:** Nova Biomedical
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-03-25
- **Primary completion:** 2021-11-11
- **Final completion:** 2021-12-15
- **Target enrollment:** 628 (ACTUAL)
- **Last updated:** 2021-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04096313

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04096313, "Evaluation of the Analytical Performance of ALLEGRO™ Instrument". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04096313. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*